Filed: 2/17/2026ACC: 0001420506-26-000584
📋 What this filing means
CALIGAN PARTNERS LP filed this quarterly 13F‑HR report disclosing 21 equity positions with a total reported market value of $1.21B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
21
Positions
$1.21B
Total AUM (reported)
36.47M
Total Shares
Allocation by class
COM$672.41M55.4%
COM NEW$329.60M27.1%
SPONSORED ADS$195.80M16.1%
ADS$9.30M0.8%
COM SHS$7.68M0.6%
Portfolio Concentration
Top 3$659.85M54.3%
4–10$423.68M34.9%
11–25$131.26M10.8%
Top 3 weight
54.3%
Top 10 weight
89.2%
Voting Authority Distribution
Total shares with voting rights: 36.47M
Sole
Full voting authority
36.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole21
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings21
Rows:
LIQUIDIA CORPORATION
SOLEShares8.12M
TypeSH
Market value$280.02M
23.05%
Sole
8.12M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares1.45M
TypeSH
Market value$195.80M
16.12%
Sole
1.45M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares5.07M
TypeSH
Market value$184.03M
15.15%
Sole
5.07M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares1.28M
TypeSH
Market value$102.26M
8.42%
Sole
1.28M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.70M
TypeSH
Market value$78.66M
6.48%
Sole
1.70M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares1.55M
TypeSH
Market value$68.08M
5.60%
Sole
1.55M
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares3.01M
TypeSH
Market value$54.95M
4.52%
Sole
3.01M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.10M
TypeSH
Market value$49.27M
4.06%
Sole
1.10M
Shared
0.00
None
0.00
INHIBRX BIOSCIENCES INC
SOLEShares473.56K
TypeSH
Market value$37.41M
3.08%
Sole
473.56K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares3.73M
TypeSH
Market value$33.05M
2.72%
Sole
3.73M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares944.26K
TypeSH
Market value$24.82M
2.04%
Sole
944.26K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares550.19K
TypeSH
Market value$22.79M
1.88%
Sole
550.19K
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares644.40K
TypeSH
Market value$21.83M
1.80%
Sole
644.40K
Shared
0.00
None
0.00
AVALO THERAPEUTICS INC
SOLEShares881.53K
TypeSH
Market value$16.01M
1.32%
Sole
881.53K
Shared
0.00
None
0.00
ANIKA THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$13.79M
1.14%
Sole
1.44M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares925.07K
TypeSH
Market value$9.96M
0.82%
Sole
925.07K
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares2M
TypeSH
Market value$9.30M
0.77%
Sole
2M
Shared
0.00
None
0.00
VERRICA PHARMACEUTICALS INC
SOLEShares923.91K
TypeSH
Market value$7.68M
0.63%
Sole
923.91K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS INC
SOLEShares90K
TypeSH
Market value$2.45M
0.20%
Sole
90K
Shared
0.00
None
0.00
SPRUCE BIOSCIENCES INC
SOLEShares20.51K
TypeSH
Market value$1.79M
0.15%
Sole
20.51K
Shared
0.00
None
0.00
ELEDON PHARMACEUTICALS INC
SOLEShares555.98K
TypeSH
Market value$839.5K
0.07%
Sole
555.98K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LIQUIDIA CORPORATIONSOLE | COM NEW | 8.12M | SH | $280.02M 23.05% | 8.12M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 1.45M | SH | $195.80M 16.12% | 1.45M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 5.07M | SH | $184.03M 15.15% | 5.07M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 1.28M | SH | $102.26M 8.42% | 1.28M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.70M | SH | $78.66M 6.48% | 1.70M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 1.55M | SH | $68.08M 5.60% | 1.55M | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 3.01M | SH | $54.95M 4.52% | 3.01M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.10M | SH | $49.27M 4.06% | 1.10M | 0.00 | 0.00 |
INHIBRX BIOSCIENCES INCSOLE | COM | 473.56K | SH | $37.41M 3.08% | 473.56K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 3.73M | SH | $33.05M 2.72% | 3.73M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 944.26K | SH | $24.82M 2.04% | 944.26K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 550.19K | SH | $22.79M 1.88% | 550.19K | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM NEW | 644.40K | SH | $21.83M 1.80% | 644.40K | 0.00 | 0.00 |
AVALO THERAPEUTICS INCSOLE | COM NEW | 881.53K | SH | $16.01M 1.32% | 881.53K | 0.00 | 0.00 |
ANIKA THERAPEUTICS INCSOLE | COM | 1.44M | SH | $13.79M 1.14% | 1.44M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 925.07K | SH | $9.96M 0.82% | 925.07K | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 2M | SH | $9.30M 0.77% | 2M | 0.00 | 0.00 |
VERRICA PHARMACEUTICALS INCSOLE | COM SHS | 923.91K | SH | $7.68M 0.63% | 923.91K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS INCSOLE | COM | 90K | SH | $2.45M 0.20% | 90K | 0.00 | 0.00 |
SPRUCE BIOSCIENCES INCSOLE | COM NEW | 20.51K | SH | $1.79M 0.15% | 20.51K | 0.00 | 0.00 |
ELEDON PHARMACEUTICALS INCSOLE | COM | 555.98K | SH | $839.5K 0.07% | 555.98K | 0.00 | 0.00 |